Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.46 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 6/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octanol SCHEMBL492895 | 0.98 | LMNA (0.61) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| Cetyl Alcohol SCHEMBL7713541 | 0.98 | LMNA (0.61) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| 1-Hexanol SCHEMBL537293 | 0.98 | LMNA (0.61) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| 1-Heptanol SCHEMBL2461694 | 0.98 | LMNA (0.61) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| Nonanol SCHEMBL10363769 | 0.98 | LMNA (0.61) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| 1-Hexanol SCHEMBL20395883 | 0.96 | ALDH1A1 (0.58) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| 1-Pentanol SCHEMBL28324770 | 0.96 | ALDH1A1 (0.58) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| Hexane SCHEMBL5393958 | 0.95 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| Heptane SCHEMBL10663246 | 0.93 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR | |
| Hexane SCHEMBL5311101 | 0.93 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10SMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101805344-A | Purification method of monomeric compound in root bark of shaggy-fruited dittany | NANJING ZELANG MEDICAL TECH CO | 2010-08-18 | — | — | CN | claimed |
| CN-108101841-B | Method for preparing indacaterol or salt thereof | 江苏恒瑞医药股份有限公司 | 2021-04-06 | — | — | CN | disclosed |
| CN-110412831-A | Photosensitive polymer combination | TAMURA SEISAKUSHO KK | 2019-11-05 | — | — | CN | disclosed |
| CN-110297396-A | Curable resin composition for ink-jet | 株式会社田村制作所 | 2019-10-01 | — | — | CN | disclosed |
| CN-110095938-A | Photosensitive polymer combination | 株式会社田村制作所 | 2019-08-06 | — | — | CN | disclosed |
| CN-104470962-B | Alkali-developable resin and photosensitive resin composition using same | 日本化药株式会社 | 2017-09-12 | — | — | CN | disclosed |
| WO-2017012770-A1 | ACID ADDITION SALTS OF FILGOTINIB | RATIOPHARM GMBH (DE) | 2017-01-26 | — | — | WO | disclosed |
| CN-106054526-A | ACTIVE ENERGY RAY CURABLE RESIN COMPOSITION WITH WHITE COLOR AND CURED PRODUCT THEREOF AND PRINTED WIRING BOARD | 日本化药株式会社 | 2016-10-26 | — | — | CN | disclosed |
| CN-102762519-B | Sintered body and manufacture method thereof | 住友大阪水泥股份有限公司 | 2016-08-24 | — | — | CN | disclosed |
| WO-2016091387-A1 | SALTS OF IDELALISIB | RATIOPHARM GMBH (DE) | 2016-06-16 | — | — | WO | disclosed |
| EP-1717276-B1 | HETEROPOLYCYCLIC COMPOUND AND DYE | UNIV KOCHI (JP) | 2010-12-29 | — | — | EP | disclosed |
| CN-101805344-A | Purification method of monomeric compound in root bark of shaggy-fruited dittany | NANJING ZELANG MEDICAL TECH CO | 2010-08-18 | — | — | CN | disclosed |
| US-7408072-B2 | Heteropolycyclic compound and dye | KOCHI UNIVERSITY (JP) | 2008-08-05 | — | — | US | disclosed |
| US-20070185338-A1 | Benzo[c]carbazoles, benzo[b]naphthofurans, benzo[kl]xanthenes, and benzo[kl]acridines oxo- and tertiary amine-substituted; high luminescence intensities; heat resistance, light resistance, solubility, dispersibility in resist materials; emit light in solution and in solid state | KOCHI UNIVERSITY (JP) | 2007-08-09 | — | — | US | disclosed |
| EP-1717276-A1 | HETEROPOLYCYCLIC COMPOUND AND DYE | Kochi University (JP) | 2006-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185338-A1 | Benzo[c]carbazoles, benzo[b]naphthofurans, benzo[kl]xanthenes, and benzo[kl]acridines oxo- and tertiary amine-substituted; high luminescence intensities; heat resistance, light resistance, solubility, dispersibility in resist materials; emit light in solution and in solid state | ABCG2, IK, XDH | ALDH1A1 601/4885LMNA 151/4885HSD17B10 860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.